Biovie Inc is a biotechnology company focused on developing innovative therapeutic solutions for neurological and psychiatric disorders
The company is dedicated to advancing its proprietary drug candidates through rigorous clinical research, aiming to address unmet medical needs in these fields. By leveraging cutting-edge science and technology, Biovie Inc seeks to improve treatment options and outcomes for patients suffering from various conditions, demonstrating a commitment to enhancing quality of life through effective healthcare solutions.
NEW YORK, NY / ACCESS Newswire / February 22, 2025 / New to The Street is set to deliver an engaging broadcast on Bloomberg Television this evening at 6:30 PM EST as sponsored programming. The show will spotlight breakthrough companies and innovative market strategies that are shaping the future of healthcare, technology, and sustainable development.
NEW YORK, NY / ACCESSWIRE / January 13, 2025 / New to The Street, a leading FMW Media production, is thrilled to announce its partnership with BioVie Inc. (NASDAQBIVI), a clinical-stage biopharmaceutical company developing innovative therapies for neurodegenerative disorders and advanced liver disease. This partnership will launch a dynamic six-part media campaign designed to amplify BioVie's groundbreaking work to audiences across multiple platforms.
NEW YORK, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against BioVie Inc. (NASDAQBIVI) on behalf of long-term stockholders following a class action complaint that was filed against BioVie on January 19, 2024 with a Class Period from August 5, 2021 to November 29, 2023. Our investigation concerns whether the board of directors of BioVie have breached their fiduciary duties to the company.
ORLANDO, FL / ACCESSWIRE / October 11, 2024 / RedChip Companies will air interviews with BioVie, Inc. (Nasdaq:BIVI) and Genetic Technologies Limited (Nasdaq:GENE)(ASX:GTG) on the RedChip Small Stocks, Big Money™ show, a sponsored program on Bloomberg TV, this Saturday, October 12, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
